Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E6011 (Quetmolimab) in Japanese Subjects With Crohn's Disease
NCT02039063Phase 2Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Apr 2014
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of quetmolimab in Crohn's disease, sponsored by EA Pharma Co., Ltd.. Started Apr 2014; status: completed.
02
Drugs
quetmolimab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02039063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039063.